Monthly News Roundup - May 2015
Viberzi and Xifaxan FDA-Approved For Diarrhea-Predominant IBS
Irritable bowel syndrome with diarrhea (IBS-D) may affect up to 15 million Americans, especially women, and treatment options are limited. In response, the U.S. Food and Drug...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news